Sarcopenia is defined as a progressive and generalized loss of skeletal muscle mass and function (i.e., muscle power, muscle strength, and physical performance). [1][2][3][4][5] Since 2016, it has been recognized as a disease. 6 People aged 50 years and older lose 1% of skeletal muscle mass, 2% of gait speed, and 1.9 to 5.0% of handgrip strength per year, 7,8 and these variables have been used for the assessment of sarcopenia by renowned organizations. 9 However, the cause and pathogenesis of sarcopenia are not fully understood; the target in sarcopenia treatment is to improve patient survival and quality of life.Sarcopenia is highly prevalent in older adults, 10 and the incidence of arterial hypertension is over 70% in this population. Data from population studies have shown that the prevalence of hypertension is increased in patients with sarcopenia. 11 Hypertension pharmacotherapy usually consists of single therapy or a combination of different medications.